Shifts in the clinical trial map drive market growth
Global health crises and geopolitical events have accelerated changes in the clinical research landscape, with a resulting focus on emerging pharmaceutical markets. This change naturally comes with opportunity, but equally a level of uncertainty around building efficient supply chains, maintaining patient focus and navigating global regulations.
Oximio is an international clinical trial service provider, with logistics, sourcing and patient-focused services in emerging and established pharmaceutical markets across the world.
Our patient focus and global depot locations provide us with the agility to tap into emerging markets across EEU and MEA. This, coupled with our local regulatory knowledge and global awareness encapsulates our total customer solutions including:
- A global network spanning ten owned depots with an extensive partner set-up in key locations
- Authorisation to act as IoR and EoR across the network
- Establishment of the first clinical trials transit warehouse in Kenya
Find out more about new opportunities emerging from shifts in the clinical trial map
"*" indicates required fields
